INDV — Indivior Pharmaceuticals, Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapSuper Stock

Annual balance sheet for Indivior Pharmaceuticals,, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	C2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	10-K	10-K
Standards:	IFRS	IFRS	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,102	893	410	320	195
Net Total Accounts Receivable
Net Total Receivables	215	225	254	287	255
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,444	1,259	1,266	827	652
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	95	85	124	139	170
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,832	1,769	1,760	1,316	1,201
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	804	1,019	1,290	924	914
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,629	1,718	1,951	1,653	1,299
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	203	51	-191	-337	-98
Total Liabilities & Shareholders' Equity	1,832	1,769	1,760	1,316	1,201
Total Common Shares Outstanding